Supplementary Figures S1-S3 from the EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer

Kazuo Yasumoto,Tadaaki Yamada,Atsuhiro Kawashima,Wei Wang,Qi Li,Ivan Shterev Donev,Shinji Tacheuchi,Hisatsugu Mouri,Kaname Yamashita,Koushiro Ohtsubo,Seiji Yano

DOI: https://doi.org/10.1158/1078-0432.22442435

2023-01-01

Abstract:Supplementary Figures S1-S3.

What problem does this paper attempt to address?

in CXCR 4-Expressing Gastric Cancer EGF-like Growth Factor Promote Peritoneal Carcinomatosis The EGFR Ligands Amphiregulin and Heparin-Binding

K. Yasumoto,Tadaaki Yamada,A. Kawashima,Wei Wang,Qi Li,I. Donev,Shinji Tacheuchi,H. Mouri,K. Yamashita,K. Ohtsubo,S. Yano

2011-01-01

Abstract:Purpose: Peritoneal carcinomatosis, often associated with malignant ascites, is the most frequent cause of death in patients with advanced gastric cancer. We previously showed that the CXCR4/CXCL12 axis is involved in the development of peritoneal carcinomatosis from gastric cancer. Here, we investigated whether epidermal growth factor receptor (EGFR) ligands are also involved in the development of peritoneal carcinomatosis from gastric cancer. Experimental Design: The functional involvement of expression of the ErbB family of receptors and/or EGFR ligands was examined in CXCR4-expressing human gastric cancer cells and fibroblasts, clinical samples (primary tumors and ascites), and an animal model. Results: High concentration of the EGFR ligands amphiregulin and heparin-binding EGF-like growth factor (HB-EGF), as well as of CXCL12, were present in malignant ascites. Human gastric cancer cell lines and primary gastric tumors, with high potential to generate peritoneal carcinomatosis, expressed high levels of EGFR and CXCR4 mRNA and protein. Both amphiregulin and HB-EGF enhanced the proliferation, migration, and functional CXCR4 expression in highly CXCR4-expressing gastric cancer NUGC4 cells. Amphiregulin strongly enhanced the proliferation of NUGC4 cells, whereas HB-EGFmarkedly induced the migration of fibroblasts. Moreover, HB-EGF and CXCL12 together enhanced TNFa-converting enzyme (TACE)-dependent amphiregulin shedding from NUGC4 cells. In an experimental peritoneal carcinomatosis model in mice, cetuximab effectively reduced tumor growth and ascites formation. Conclusions: Our results strongly suggest that the EGFR ligands amphiregulin and HB-EGF play an important role, interacting with the CXCL12/CXCR4 axis, in the development of peritoneal carcinomatosis from gastric cancer, indicating that these two axes may be potential therapeutic targets for peritoneal carcinomatosis of gastric carcinoma. Clin Cancer Res; 17(11); 3619–30. 2011 AACR.
Supplementary Figures 1-2 from Serglycin is a Theranostic Target in Nasopharyngeal Carcinoma That Promotes Metastasis

Xin-Jian Li,Choon Kiat Ong,Yun Cao,Yan-Qun Xiang,Jian-Yong Shao,Aikseng Ooi,Li-Xia Peng,Wen-Hua Lu,Zhongfa Zhang,David Petillo,Li Qin,Ying-Na Bao,Fang-Jing Zheng,Claramae Shulyn Chia,N. Gopalakrishna Iyer,Tie-Bang Kang,Yi-Xin Zeng,Khee Chee Soo,Jeffrey M. Trent,Bin Tean Teh,Chao-Nan Qian

DOI: https://doi.org/10.1158/0008-5472.22390676.v1

2023-01-01

Abstract:Supplementary Figures 1-2 from Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis
Supplementary Figure 3 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377147

2023-01-01

Abstract:Supplementary Figure 3 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figure 4 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377144

2023-01-01

Abstract:Supplementary Figure 4 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377150.v1

2023-01-01

Abstract:Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figure 1 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377153

2023-01-01

Abstract:Supplementary Figure 1 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figures S1-S4 from Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Ivan S. Donev,Wei Wang,Tadaaki Yamada,Qi Li,Shinji Takeuchi,Kunio Matsumoto,Takao Yamori,Yasuhiko Nishioka,Saburo Sone,Seiji Yano

DOI: https://doi.org/10.1158/1078-0432.22442205

2023-01-01

Abstract:Supplementary Figures S1-S4.
Supplementary Figure 5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377141

2023-01-01

Abstract:Supplementary Figure 5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figure 1 from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Li Zhang,Carla Castanaro,Bo Luan,Katie Yang,Liangfen Fan,Jeanette L. Fairhurst,Ashique Rafique,Terra B. Potocky,Jing Shan,Frank J. Delfino,Ergang Shi,Tammy Huang,Joel H. Martin,Gang Chen,Douglas MacDonald,John S. Rudge,Gavin Thurston,Christopher Daly

DOI: https://doi.org/10.1158/1535-7163.22500492

2023-01-01

Abstract:PDF - 78K, Effect of REGN1400 and REGN955 on ligand-induced signaling by ERBB3 and EGFR, respectively.
Supplementary Figure Legends 1-5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377138

2023-01-01

Abstract:Supplementary Figure Legends 1-5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Methods, Figures 1-5 from P190rhogef (rgnef) Promotes Colon Carcinoma Tumor Progression Via Interaction with Focal Adhesion Kinase

Hong-Gang Yu,Ju-Ock Nam,Nichol L. G. Miller,Isabelle Tanjoni,Colin Walsh,Lei Shi,Linda Kim,Xiao Lei Chen,Alok Tomar,Ssang-Taek Lim,David D. Schlaepfer

DOI: https://doi.org/10.1158/0008-5472.22387758

2023-01-01

Abstract:Supplementary Methods, Figures 1-5 from p190RhoGEF (Rgnef) Promotes Colon Carcinoma Tumor Progression via Interaction with Focal Adhesion Kinase
Supplementary Figure Legends 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content Via Stromal-Derived Factor-1α/CXCR4 Axis

Nan Song,Yujie Huang,Hubing Shi,Shaopeng Yuan,Yanping Ding,Xiaomin Song,Yan Fu,Yongzhang Luo

DOI: https://doi.org/10.1158/0008-5472.22377603

2023-01-01

Abstract:Supplementary Figure Legends 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis
Supplementary Figure from EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis Via Activating FAK Signal

Haojie Li,Xuhong Fu,Junjie Zhao,Chen Li,Lingmeng Li,Peiyan Xia,Jianping Guo,Wenyi Wei,Rong Zeng,Jiarui Wu,Yihong Sun,Liyu Huang,Xuefei Wang

DOI: https://doi.org/10.1158/1541-7786.22527882

2023-01-01

Abstract:Supplementary Figure from EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal
Supplementary Figure 4 from CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

Qiang Gao,Ying-Jun Zhao,Xiao-Ying Wang,Shuang-Jian Qiu,Ying-Hong Shi,Jian Sun,Yong Yi,Jie-Yi Shi,Guo-Ming Shi,Zhen-Bin Ding,Yong-Sheng Xiao,Zhong-Hua Zhao,Jian Zhou,Xiang-Huo He,Jia Fan

DOI: https://doi.org/10.1158/0008-5472.22391666.v1

2023-01-01

Abstract:PDF file - 1.6MB, The effects CXCR6-konckdown on expression of epithelial-to-mesenchymal transition markers and signaling molecules of hepatoma cells
Supplementary Figure 3 from Cooperativity of E-cadherin and Smad4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis

Jun Won Park,Seok Hoon Jang,Dong Min Park,Na Jung Lim,Chuxia Deng,Dae Yong Kim,Jeffrey E. Green,Hark Kyun Kim

DOI: https://doi.org/10.1158/1541-7786.22514238

2023-01-01

Abstract:PDF - 234K, Immunohistochemistry for the tissue origin.
Supplementary Table 1, Figures 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis

Nan Song,Yujie Huang,Hubing Shi,Shaopeng Yuan,Yanping Ding,Xiaomin Song,Yan Fu,Yongzhang Luo

DOI: https://doi.org/10.1158/0008-5472.22377600.v1

2023-01-01

Abstract:Supplementary Table 1, Figures 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis
Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73<sup>+</sup> Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer

Guoming Hu,Pu Cheng,Jun Pan,Shimin Wang,Qingqing Ding,Jing Zhou,Cheng Liu,Xuan Shao,Liming Huang,Jikun Huang

DOI: https://doi.org/10.1158/2326-6066.22542160.v1

2023-01-01

Abstract:Supplemental Figures 1-12 and Supplementary Tables 1-3
Supplementary Figures 1-6 from Combined EGFR/MET or EGFR/HSP90 Inhibition is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET

Lu Xu,Eiki Kikuchi,Chunxiao Xu,Hiromichi Ebi,Dalia Ercan,Katherine A. Cheng,Robert Padera,Jeffrey A. Engelman,Pasi A. Jänne,Geoffrey I. Shapiro,Takeshi Shimamura,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22391819.v1

2023-01-01

Abstract:PDF file - 1.4MB, Supplemental Figure 1. MET is inducible in MET, TD/MET, and TL/MET models Supplemental Figure 2. Quantification of hMET expression in mouse models Supplemental Figure 3. Comparison of the tumor counts in mutant EGFR lung tumors with or without expression of hMET. Supplemental Figure 4. Representative MRI images prior to and after treatment in TL and TL/MET mice. Supplemental Figure 5. Xenografts of HCC827GR6 cells ectopically expressing EGFR E746_A750del/T790M are sensitive to the combination of WZ4002 and 17-DMAG. Supplemental Figure 6. The WZ4002/crizotinib or WZ4002/17-DMAG combinations suppress phosphorylation of EGFR, Akt, and Erk in TD and TD/MET to a greater extent than individual treatments
Supplementary Figures 1-10 from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Pierre Saintigny,Erminia Massarelli,Steven Lin,Young-Ho Ahn,Yulong Chen,Sangeeta Goswami,Baruch Erez,Michael S. O'Reilly,Diane Liu,J. Jack Lee,Li Zhang,Yuan Ping,Carmen Behrens,Luisa M. Solis Soto,John V. Heymach,Edward S. Kim,Roy S. Herbst,Scott M. Lippman,Ignacio I. Wistuba,Waun Ki Hong,Jonathan M. Kurie,Ja Seok Koo

DOI: https://doi.org/10.1158/0008-5472.22394124

2023-01-01

Abstract:<p>PDF file - 581K, Supplementary Figure 1: Distribution of cytoplasmic CXCR2 protein expression in 262 non-small cell lung cancer cell lines. Supplementary Figure 2: CXCR2 expression in tumor cells according to EGFR and KRAS mutation status. Supplementary Figure 3: Kaplan-Meier curves Supplementary Figure 4: Distribution of expression of CXCR2 and its ligand genes Supplementary Figure 5: CXCR2/CXCR2 ligands cluster is associated with a worse overall survival in patients with lung adenocarcinoma (N=442) Supplementary Figure 6: TTF-1 gene expression was more frequently lower in lung adenocarcinomas Supplementary Figure 7: The first two principal components were computed using expression of CXCR2 and its ligand genes Supplementary Figure 8: The first two principal components were computed using expression of CXCR2 and its ligand genes Supplementary Figure 9: Expression of (A) CXCL1, (B) CXCL2, (C) CXCL3, and (D) CXCL6 genes was negatively correlated with the level of their promoter methylation as indicated by average beta-value. Supplementary Figure 10: The effect of two doses of decitabine</p>
Supplementary Figure 3 from CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

Qiang Gao,Yingjun Zhao,Xiaoying Wang,Shuang‐Jian Qiu,Ying‐Hong Shi,Jun Sun,Yi Yao,Jing Shi,Guo‐Ming Shi,Zhen–Bin Ding,Xiao Ye,Zhao Zhen,Jing Zhou,Xiayun He,Jia Fan

DOI: https://doi.org/10.1158/0008-5472.22391669

2023-01-01

Abstract:PDF file - 856K, Effects of CXCL16-knockdown on HCC cell invasion and cytokine secretion in vitro, and tumor growth in vivo

Supplementary Figures S1-S3 from the EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer

in CXCR 4-Expressing Gastric Cancer EGF-like Growth Factor Promote Peritoneal Carcinomatosis The EGFR Ligands Amphiregulin and Heparin-Binding

Supplementary Figures 1-2 from Serglycin is a Theranostic Target in Nasopharyngeal Carcinoma That Promotes Metastasis

Supplementary Figure 3 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figure 4 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figure 1 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figures S1-S4 from Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Supplementary Figure 5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figure 1 from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Supplementary Figure Legends 1-5 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Methods, Figures 1-5 from P190rhogef (rgnef) Promotes Colon Carcinoma Tumor Progression Via Interaction with Focal Adhesion Kinase

Supplementary Figure Legends 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content Via Stromal-Derived Factor-1α/CXCR4 Axis

Supplementary Figure from EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis Via Activating FAK Signal

Supplementary Figure 4 from CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

Supplementary Figure 3 from Cooperativity of E-cadherin and Smad4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis

Supplementary Table 1, Figures 1-9 from Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis

Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73&lt;sup&gt;+&lt;/sup&gt; Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer

Supplementary Figures 1-6 from Combined EGFR/MET or EGFR/HSP90 Inhibition is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET

Supplementary Figures 1-10 from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Supplementary Figure 3 from CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73<sup>+</sup> Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer